Two researchers and the struggle to develop a treatment
The Cancer Killers follows Australian scientists Jennifer MacDiarmid and Himanshu Brahmbhatt through the development of an experimental approach to cancer treatment. Filmed over ten years, the documentary concentrates on the long relationship between laboratory research, patients, investment and the survival of their company, EnGeneIC.
The scientists' proposed technology is called EnGeneIC Dream Vector, or EDV. SBS describes it through the image of a microscopic Trojan horse intended to deliver treatment into cancer cells while also engaging the immune system. The documentary follows the researchers' ambition for this approach; that ambition should not be confused with proof of a universal cure.
The distance between a promising idea and clinical use
The story includes early human trials in Melbourne in 2009, later work in Australia and the United States, and persistent financial pressure. The scientists must seek funding while continuing research, making the business decisions part of the scientific story rather than background administration. SBS frames the resulting journey around resilience, setbacks and the difficulty of bringing a discovery to market.
Director Judy Rymer is also credited as producer and narrator in Apple TV's listing. The BBC describes the series through two linked questions: whether investors believe the scientists, and what the process means for patients. That human and commercial focus distinguishes the programme from an instructional explanation of a particular treatment.
